Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	20 mg	71
Overall Study	STARTED	40 mg	69
Overall Study	STARTED	80 mg	71
Overall Study	STARTED	10 mg Haloperidol	73
Overall Study	STARTED	Placebo	72
Overall Study	COMPLETED	20 mg	27
Overall Study	COMPLETED	40 mg	28
Overall Study	COMPLETED	80 mg	31
Overall Study	COMPLETED	10 mg Haloperidol	29
Overall Study	COMPLETED	Placebo	36
Overall Study	NOT COMPLETED	20 mg	44
Overall Study	NOT COMPLETED	40 mg	41
Overall Study	NOT COMPLETED	80 mg	40
Overall Study	NOT COMPLETED	10 mg Haloperidol	44
Overall Study	NOT COMPLETED	Placebo	36

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00044044/flow